BlackRock Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

BlackRock Group’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-574,642	Closed	-$30.7M	–	3126
2016 Q1	$30.7M	Buy	574,642 +102,522	+22%	+$7.57M	0.02%	699
2015 Q4	$53.3M	Buy	472,120 +4,017	+0.9%	+$443K	0.03%	563
2015 Q3	$55.1M	Buy	468,103 +345,010	+280%	+$45.1M	0.03%	534
2015 Q2	$9.53M	Buy	123,093 +11,129	+10%	+$730K	0.01%	980
2015 Q1	$6.48M	Buy	111,964 +17,047	+18%	+$724K	﹤0.01%	1066
2014 Q4	$3.06M	Buy	+94,917	New	+$2.85M	﹤0.01%	1301
2014 Q3	–	Sell	-1,409	Closed	-$25K	–	2960
2014 Q2	$25K	Buy	+1,409	New	+$22.7K	﹤0.01%	2755

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

BlackRock Group's ANAC Position: Q2 2016 in Review

BlackRock Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 574,642 shares — an estimated $30.7M sold.

BlackRock Group first reported a position in ANAC in Q2 2014 and held it in 7 quarters. The position peaked at $55.1M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

BlackRock Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
BlackRock Group sold 574,642 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $30.7M.
BlackRock Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2014 and held it in 7 quarters.
BlackRock Group's ANACOR PHARMACEUTICALS INC COM position peaked at $55.1M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on BlackRock Group's 13F filing for Q2 2016, filed 10 Aug 2016.